跳转至内容
Merck
所有图片(1)

主要文件

05-533

Sigma-Aldrich

磷酸化CaM激酶II抗体,α亚基,Thr286,克隆22B1

clone 22B1, Upstate®, from mouse

别名:

Anti-Anti-CAMKA, Anti-Anti-CaMKIINalpha, Anti-Anti-CaMKIIalpha, Anti-Anti-MRD53, Anti-Anti-MRT63

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

mouse

品質等級

抗體表格

purified antibody

抗體產品種類

primary antibodies

無性繁殖

22B1, monoclonal

物種活性

rat

製造商/商標名

Upstate®

技術

western blot: suitable

同型

IgG1

UniProt登錄號

運輸包裝

wet ice

目標翻譯後修改

phosphorylation (pThr286)

基因資訊

human ... CAMK2A(815)

特異性

磷酸化CaM激酶II α亚基

免疫原

对应于大鼠CaM激酶IIα亚基残基281-294的肽;可识别苏氨酸286处磷酸化的CaM激酶II

應用

可使用这种磷酸化CaM激酶II抗体(α亚基,Thr286,克隆22B1)检测磷酸化CaM激酶II,该抗体经验证可用于WB。

品質

已通过免疫印迹对大鼠脑微粒体蛋白的制剂进行常规评估

標靶描述

50kDa

外觀

形式:纯化

法律資訊

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Su-Ying Cui et al.
Journal of neurochemistry, 136(3), 609-619 (2015-11-13)
The Ca(2+) modulation in the dorsal raphe nucleus (DRN) plays an important role in sleep-wake regulation. Calmodulin-dependent kinase II (CaMKII) is an important signal-transducing molecule that is activated by Ca(2+) . This study investigated the effects of intracellular Ca(2+) /CaMKII
Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth.
Kim, JH; Lee, JA; Song, YM; Park, CH; Hwang, SJ; Kim, YS; Kaang, BK; Son, H
Faseb Journal null
B L Patton et al.
Molecular biology of the cell, 4(2), 159-172 (1993-02-01)
We have visualized the distribution of autophosphorylated type II CaM kinase in neural tissue with the use of two complementary antibodies: a monoclonal antibody that binds to the alpha and beta subunits of the kinase only when they are autophosphorylated
Mar Cuadrado-Tejedor et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 42(2), 524-539 (2016-08-24)
The targeting of two independent but synergistic enzymatic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD). Here we report the discovery of
Comparative biology of cystic fibrosis animal models.
Fisher, JT; Zhang, Y; Engelhardt, JF
Methods in Molecular Biology null

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门